Skip to main content

Table 1 Clinical characteristics of patients enrolled in the study for the explorative phase

From: Glycosylation deficiency of lipopolysaccharide-binding protein and corticosteroid-binding globulin associated with activity and response to treatment for rheumatoid arthritis

 HVRA
n1515
Female1515
Age—mean (range)41 years (24–48)43 years (25–49)
BMI—mean (range)22 (19–28)23 (17–36)
Disease duration—mean (range)86 months (4–300)
DAS28-CRP4.9 (3.6–8)
ESR28.5 (2–67)
CRP+ %61
RF+ %66
Anti-CCP+ %83
Treatment %  
Corticoids40
NSAID46
MTX33
Leflunomide13
Biologics40
  1. HV healthy volunteers, RA rheumatoid arthritis, BMI body mass index, ESR erythrocyte sedimentation rate, CRP C-Reactive Protein, RF rheumatoid factor; anti-CCP anti-cyclic citrullinated peptide, NSAID nonsteroidal anti-inflammatory drugs, MTX methotrexate